Medadvisor Ltd (MDR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medadvisor Ltd (MDR) has a cash flow conversion efficiency ratio of 5.093x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-8.24 Million ≈ $-5.83 Million USD) by net assets (AU$-1.62 Million ≈ $-1.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MDR net asset quality score to measure how much of total assets are equity-financed.
Medadvisor Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Medadvisor Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Medadvisor Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Medadvisor Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medadvisor Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
hGears AG
XETRA:HGEA
|
-0.050x |
|
Spring Art Holdings Bhd
KLSE:0216
|
0.013x |
|
Euroland Corporate SA
PA:MLERO
|
N/A |
|
Intensity Therapeutics, Inc. Common stock
NASDAQ:INTS
|
-0.183x |
|
TWZ Corporation Public Company Limited
BK:TWZ
|
-0.005x |
|
CalciMedica, Inc. Common Stock
NASDAQ:CALC
|
0.731x |
|
Meta Epsi Tbk PT
JK:MTPS
|
0.244x |
|
Income Asset Management Group Ltd
AU:IAM
|
-2.381x |
Annual Cash Flow Conversion Efficiency for Medadvisor Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Medadvisor Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Medadvisor Ltd (MDR) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$-1.62 Million ≈ $-1.14 Million |
AU$-14.37 Million ≈ $-10.16 Million |
8.880x | +8729.14% |
| 2024-06-30 | AU$51.58 Million ≈ $36.50 Million |
AU$5.19 Million ≈ $3.67 Million |
0.101x | +435.19% |
| 2023-06-30 | AU$48.46 Million ≈ $34.29 Million |
AU$-1.45 Million ≈ $-1.03 Million |
-0.030x | -338.61% |
| 2022-06-30 | AU$34.55 Million ≈ $24.44 Million |
AU$-236.32K ≈ $-167.21K |
-0.007x | +97.34% |
| 2021-06-30 | AU$48.85 Million ≈ $34.56 Million |
AU$-12.54 Million ≈ $-8.88 Million |
-0.257x | +49.65% |
| 2020-06-30 | AU$17.02 Million ≈ $12.04 Million |
AU$-8.68 Million ≈ $-6.14 Million |
-0.510x | +36.52% |
| 2019-06-30 | AU$8.64 Million ≈ $6.12 Million |
AU$-6.95 Million ≈ $-4.91 Million |
-0.803x | -272.90% |
| 2018-06-30 | AU$15.17 Million ≈ $10.73 Million |
AU$-3.27 Million ≈ $-2.31 Million |
-0.215x | +16.19% |
| 2017-06-30 | AU$9.35 Million ≈ $6.62 Million |
AU$-2.40 Million ≈ $-1.70 Million |
-0.257x | +75.12% |
| 2016-06-30 | AU$2.46 Million ≈ $1.74 Million |
AU$-2.55 Million ≈ $-1.80 Million |
-1.033x | -123.13% |
| 2015-06-30 | AU$-106.88K ≈ $-75.63K |
AU$-477.40K ≈ $-337.79K |
4.467x | +155.67% |
| 2014-06-30 | AU$310.98K ≈ $220.04K |
AU$-2.50 Million ≈ $-1.77 Million |
-8.024x | -2576.88% |
| 2013-06-30 | AU$11.11 Million ≈ $7.86 Million |
AU$-3.33 Million ≈ $-2.36 Million |
-0.300x | -44.27% |
| 2012-06-30 | AU$2.78 Million ≈ $1.97 Million |
AU$-577.73K ≈ $-408.78K |
-0.208x | -5068.77% |
| 2011-06-30 | AU$3.14 Million ≈ $2.22 Million |
AU$-12.62K ≈ $-8.93K |
-0.004x | -- |
About Medadvisor Ltd
Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anm… Read more